Evidence & HTA Support

Evidence that secures
payer decisions

Devising integrated evidence programmes and HTA-ready dossiers to demonstrate value, de-risk reimbursement strategies and accelerate payer coverage decisions across regional healthcare systems.

From evidence planning to payer confidence

We plan integrated evidence strategies that link clinical trials, real-world data and economic models to produce HTA-grade submissions. Along with that, we work diligently to address evidence gaps for country-level success.

Building credibility through precision

Integrated evidence planning

We design staged evidence plans integrating trial data, RWE and economic models to address HTA requirements alongside payer & clinician decision points.

HTA strategy and submission support

We prepare HTA strategies and submission dossiers, conducting literature reviews and local adaptations to optimise for HTA outcomes.

Explore our
Value & Access Suite

Strategic Market Assessment & Planning

We conduct comprehensive landscape analyses to help you identify market opportunities, inform early access strategies and guide launch sequencing.

Product Value & Pricing Strategy

We develop and test Target Product Profiles (TPP), assess willingness-to-pay and craft compelling value propositions to support your market positioning.

Policy, Advocacy & Stakeholder Engagement

We develop position papers, engage with key stakeholders and support policy to build the ecosystem that will drive your success.

Negotiation & Access Agreements

We formulate tender & managed entry strategies and support negotiations to secure favourable pricing & access for your assets.

Insights designed for
execution

Know More

Navigating the UAE’s Regulatory Shift: From Ambition to

The Future of Biopharma: China and Saudi Arabia are redefining “Pharmerging”

Strategic Defense against Generic Entry for Rare Disease Products in KSA

Let's talk

Whether you're expanding into the region or rethinking your local strategy, we're here to help.